CTMX icon

CytomX Therapeutics
CTMX

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$8
86% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Mitchell Kapoor
67% 1-yr CTMX win rate
11 Nov ‘25 2 months ago
Barclays
Barclays
Etzer Darout
100% 1-yr CTMX win rate
21 Oct ‘25 2 months ago